Is insomnia a side effect of glipizide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Is Insomnia a Side Effect of Glipizide?

No, insomnia is not listed as a recognized side effect of glipizide according to FDA labeling and current clinical guidelines.

Official Side Effect Profile

The FDA-approved prescribing information for glipizide does not include insomnia among its documented adverse reactions 1. The most commonly reported side effects are:

  • Gastrointestinal disturbances (most common): nausea, diarrhea (1 in 70 patients), constipation, and gastralgia (1 in 100 patients) 1
  • Central nervous system effects: dizziness, drowsiness, and headache (each occurring in approximately 1 in 50 patients) 1
  • Dermatologic reactions: allergic skin reactions in about 1 in 70 patients 1
  • Hypoglycemia: the most clinically significant adverse effect, particularly in elderly, debilitated, or malnourished patients 1

Key Clinical Consideration: Drowsiness vs. Insomnia

Notably, glipizide causes drowsiness rather than insomnia 1. This sedating effect occurs in approximately 2% of patients and is typically transient, rarely requiring discontinuation of therapy 1.

Context on Medication-Related Insomnia

While glipizide itself does not cause insomnia, it's worth noting that:

  • Patients taking multiple medications with insomnia side effects (from other drug classes) have increased odds of insomnia symptoms (OR = 1.78) and daytime sleepiness (OR = 1.73) 2
  • However, glipizide is not among the medications identified as having insomnia as a potential side effect 2

Clinical Guideline Perspective

The 2025 American Diabetes Association guidelines list the key safety considerations for sulfonylureas (including glipizide) as hypoglycemia risk and potential cardiovascular concerns, with no mention of sleep disturbances 3.

Common Pitfall to Avoid

Do not confuse the drowsiness caused by glipizide with insomnia—these are opposite effects. If a patient on glipizide reports insomnia, investigate other causes including uncontrolled diabetes itself, concurrent medications, or comorbid conditions rather than attributing it to the glipizide 1.

References

Related Questions

What is the recommended management for a 38-year-old woman with new-onset insomnia for one week, characterized by 45‑minute sleep onset latency and early morning awakening at 4 a.m., without identifiable stressors or medication changes?
What is the differential diagnosis and recommended treatment for a 38-year-old woman with acute insomnia lasting six days?
How should I evaluate and manage a 45-year-old man presenting with insomnia, anxiety, and asthenia?
For a 49-year-old woman with chronic difficulty falling asleep, frequent nocturnal awakenings, normal examination and a previously normal thyroid‑stimulating hormone level, what additional diagnostic tests should be performed?
What is the appropriate management for a 24-year-old with insomnia who gets about 5 hours of sleep on weekdays (bed at 11:40 pm, wake at 7:40 am) and later sleep on weekends (bed at 12:52 am, wake at 10:00 am)?
Can simethicone be used to treat stomach gas pain or bloating?
In an adult patient with elevated red blood cell count, hemoglobin, and hematocrit but normal white blood cell and platelet counts, what is the likely diagnosis and how should I evaluate and manage possible polycythemia?
Can benign paroxysmal positional vertigo (BPPV) be triggered by war crystals?
How likely is sertraline to cause hypokalemia?
What is the significance of a low albumin/globulin (A/G) ratio of 1.0 in an otherwise normal comprehensive metabolic panel?
Can celecoxib (Celebrex) be used in an elderly patient, and what are the recommended dose, contraindications, and monitoring requirements?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.